Why the study?
What is the seroprevalence of protective antibodies against polioviruses in the general population of Florence, Italy?
What is the seroprevalence of protective antibodies against polioviruses in the general population of Florence, Italy?
A significant proportion of the population in Florence, Italy, particularly from age 11 onwards, lacks protective antibodies against poliovirus type 3, supporting the recommendation for a fifth dose of IPV vaccine in adolescence.
Answers are grounded in this paper and cite their sources.
Low PV3 seroprevalence from age 11 may signal waning immunity; leaves open need for adolescent IPV boosters in Italy.
OBJECTIVES: Periodical assessments of population susceptibility to polioviruses (PV) is essential for evaluating population protection and planning appropriate vaccination strategies. The aim of the current work was to assess serological protective titers against all three polioviruses in the general population of Florence. METHODS: A convenience sample of 328 sera, collected in 2009 in Florence (Central Italy) was analyzed. Samples were considered protective if neutralizing antibodies were detected at dilutions ≥1:8, according to the WHO protocols. RESULTS: The immune coverage was 75.3%, 69.2% and 46% for PV1, PV2 and PV3, respectively. The protective titers of neutralizing antibodies were generally higher in children up to 14 years of age, with 74.4% (PV1), 75.6% (PV2) and 56.7% (PV3) of seroprevalence. From the age of 11 years, most of the study subjects were seronegative for PV3. CONCLUSIONS: In a polio-free country with strong migration pressures, such as Italy, our results bring clear support to the recent recommendation of Italian health authorities to introduce a fifth dose of IPV vaccine in adolescence all over the country.
No takes yet. Share an insight, caveat, or question.
Giammanco et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: